Why This Nano-Cap Stock Might Skyrocket To $14, Per Analyst Insights

NeuroSense expands PrimeC production, partners with a contract organization, and targets early Canadian entry amid a $100–150 million forecast and analyst Buy rating.

Latest Ratings for NRSN

Date Firm Action From To
Jan 2022 Maxim Group Initiates Coverage On Buy

View More Analyst Ratings for NRSN

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *